Literature DB >> 3414803

Evidence against oxidant injury as a critical mediator of postischemic acute renal failure.

L M Gamelin1, R A Zager.   

Abstract

The purpose of this study is to confirm previous evidence for reactive oxygen species (ROS) as critical mediators of postischemic renal injury by documenting lipid peroxidation after ischemic-hypoxic insults and by demonstrating that antioxidants confer protection. Renal malondialdehyde (MDA) concentrations, an index of lipid peroxidation, were measured using uncorrected and tissue-chromagen-corrected methods in 1) cortical (C), outer medullary stripe (OMS), inner medullary (IM) whole renal tissues, and C and OMS mitochondria obtained 15 min after in vivo renal artery occlusion (RAO; x 45 min); 2) C, OMS, and IM whole tissues obtained 15 min after completing 45 min of ischemia in an isolated perfused kidney; and 3) isolated proximal tubular cell (PTC) suspensions after 45 min of hypoxia with 15 min of reoxygenation. Despite significant oxygen deprivation-induced injury in each of these systems, no significant rise in MDA concentrations could be documented, with the sole exception of the in vivo IM region (by uncorrected MDA assay only). The latter rise could be attributed to medullary vascular congestion causing a hemoglobin-induced artifact in the MDA assay. Sixty-minute in vivo RAO plus reflow also did not raise MDA. To validate the MDA assay 4.2 mM H2O2 was added to PTC. An abrupt fourfold rise in MDA resulted. Pretreatment of 30- and 45-min RAO rats with two antioxidants (allopurinol or superoxide dismutase) failed to confer functional or morphological protection. We conclude that ROS may not be critical consistent mediators of in vivo postischemic acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3414803     DOI: 10.1152/ajprenal.1988.255.3.F450

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon.

Authors:  A Mehta; C P S Sekhon; S Giri; J K Orak; A K Singh
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 2.  Reactive oxygen molecules, oxidant injury and renal disease.

Authors:  S P Andreoli
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

3.  An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury.

Authors:  M A Thornton; R Winn; C E Alpers; R A Zager
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

4.  Acute hepatic ischemic-reperfusion injury induces a renal cortical "stress response," renal "cytoresistance," and an endotoxin hyperresponsive state.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten B Frostad
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-30

5.  Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo.

Authors:  A K Salahudeen; E C Clark; K A Nath
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 6.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

7.  Lack of effect of antioxidant therapy during renal ischemia and reperfusion in dogs.

Authors:  L Kónya; P Bencsáth; G Szénási; J Fehér
Journal:  Experientia       Date:  1993-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.